Published in Neurotox Res on October 17, 2010
Induction of innate immune genes in brain create the neurobiology of addiction. Brain Behav Immun (2011) 1.77
Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J Neuroimmune Pharmacol (2012) 0.89
Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res (2014) 0.87
Glial cell modulators attenuate methamphetamine self-administration in the rat. Eur J Pharmacol (2013) 0.87
Addiction, adolescence, and innate immune gene induction. Front Psychiatry (2011) 0.86
Glial modulators as potential treatments of psychostimulant abuse. Adv Pharmacol (2014) 0.86
Neuroimmune basis of methamphetamine toxicity. Int Rev Neurobiol (2014) 0.86
The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans. Subst Abuse Rehabil (2013) 0.85
The glial cell modulators, ibudilast and its amino analog, AV1013, attenuate methamphetamine locomotor activity and its sensitization in mice. Eur J Pharmacol (2012) 0.83
Methamphetamine mediates immune dysregulation in a murine model of chronic viral infection. Front Microbiol (2015) 0.80
An Update of the Review of Neuropsychological Consequences of HIV and Substance Abuse: A Literature Review and Implications for Treatment and Future Research. Curr Drug Abuse Rev (2015) 0.79
Unique genetic factors influence sensitivity to the rewarding and aversive effects of methamphetamine versus cocaine. Behav Brain Res (2013) 0.79
Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy. Pharmacol Ther (2013) 0.79
Methamphetamine decreases CD4 T cell frequency and alters pro-inflammatory cytokine production in a model of drug abuse. Eur J Pharmacol (2015) 0.79
Impact of methamphetamine on infection and immunity. Front Neurosci (2015) 0.78
Reductions in frontocortical cytokine levels are associated with long-lasting alterations in reward valuation after methamphetamine. Neuropsychopharmacology (2015) 0.78
Methamphetamine effects on blood-brain barrier structure and function. Front Neurosci (2015) 0.78
Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate. Psychopharmacology (Berl) (2013) 0.78
Partial MHC/neuroantigen peptide constructs: a potential neuroimmune-based treatment for methamphetamine addiction. PLoS One (2013) 0.78
Methamphetamine addiction: involvement of CREB and neuroinflammatory signaling pathways. Psychopharmacology (Berl) (2016) 0.78
The Complex Interaction Between Methamphetamine Abuse and HIV-1 Pathogenesis. J Neuroimmune Pharmacol (2015) 0.77
Everyday problems with executive dysfunction and impulsivity in adults recovering from methamphetamine addiction. Addict Disord Their Treat (2016) 0.77
Methamphetamine alters microglial immune function through P2X7R signaling. J Neuroinflammation (2016) 0.76
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study. Drug Alcohol Depend (2016) 0.76
Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs. Alcohol Clin Exp Res (2015) 0.75
Differential induction of PD-1/PD-L1 in Neuroimmune cells by drug of abuse. Int J Physiol Pathophysiol Pharmacol (2015) 0.75
Cyclooxygenase activity contributes to the monoaminergic damage caused by serial exposure to stress and methamphetamine. Neuropharmacology (2013) 0.75
Peripheral ammonia and blood brain barrier structure and function after methamphetamine. Neuropharmacology (2016) 0.75
Altered energy production, lowered antioxidant potential, and inflammatory processes mediate CNS damage associated with abuse of the psychostimulants MDMA and methamphetamine. Eur J Pharmacol (2014) 0.75
Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study. Front Psychiatry (2015) 0.75
Cocaine-mediated downregulation of microglial miR-124 expression involves promoter DNA methylation. Epigenetics (2016) 0.75
mRNA changes in nucleus accumbens related to methamphetamine addiction in mice. Sci Rep (2016) 0.75
Impact of chronic methamphetamine treatment on the atherosclerosis formation in ApoE-/- mice fed a high cholesterol diet. Oncotarget (2017) 0.75
Role of microglia in methamphetamine-induced neurotoxicity. Int J Physiol Pathophysiol Pharmacol (2017) 0.75
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J Clin Exp Neuropsychol (1998) 9.33
Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry (2001) 4.37
Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci (2004) 4.14
Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Neuropsychol Rev (2007) 3.57
Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry (2004) 3.02
Increased MCP-1 and microglia in various regions of the human alcoholic brain. Exp Neurol (2007) 2.30
Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev (2008) 2.30
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome. Cancer (2005) 2.09
Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol (1998) 2.05
Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci (2008) 1.96
Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther (2004) 1.96
Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms. Neurotox Res (2007) 1.77
Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett (1996) 1.70
Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67
Amphetamine toxicities: classical and emerging mechanisms. Ann N Y Acad Sci (2010) 1.62
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
Abuse of amphetamines and structural abnormalities in the brain. Ann N Y Acad Sci (2008) 1.54
Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J Neuroimmunol (2010) 1.52
Are chemokines the third major system in the brain? J Leukoc Biol (2005) 1.50
Brain edema and breakdown of the blood-brain barrier during methamphetamine intoxication: critical role of brain hyperthermia. Eur J Neurosci (2007) 1.33
Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci (1993) 1.31
High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse (2006) 1.30
A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol (2009) 1.28
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage (2010) 1.23
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience (2004) 1.16
Methamphetamine enhances histoplasmosis by immunosuppression of the host. J Infect Dis (2009) 1.16
Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol (2002) 1.16
Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage. Ann N Y Acad Sci (2006) 1.15
Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology (2003) 1.15
Improvement by minocycline of methamphetamine-induced impairment of recognition memory in mice. Psychopharmacology (Berl) (2007) 1.12
The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse. J Neuroimmune Pharmacol (2008) 1.11
Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine. Ann N Y Acad Sci (2008) 1.10
Methamphetamine use parameters do not predict neuropsychological impairment in currently abstinent dependent adults. Drug Alcohol Depend (2009) 1.08
Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res (2010) 1.08
Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett (2007) 1.07
Repeated methamphetamine treatment impairs recognition memory through a failure of novelty-induced ERK1/2 activation in the prefrontal cortex of mice. Biol Psychiatry (2005) 1.04
Methamphetamine administration produces immunomodulation in mice. J Toxicol Environ Health A (2005) 1.04
In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. J Neurosci (1992) 1.03
Methamphetamine-induced neuroinflammation and neuronal dysfunction in the mice hippocampus: preventive effect of indomethacin. Eur J Neurosci (2010) 1.03
Methamphetamine-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters. Eur J Pharmacol (2007) 1.00
Striatal subregions are differentially vulnerable to the neurotoxic effects of methamphetamine. Brain Res (1992) 1.00
Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther (1997) 0.97
Methamphetamine enhances Hepatitis C virus replication in human hepatocytes. J Viral Hepat (2008) 0.97
Melatonin attenuates methamphetamine-induced overexpression of pro-inflammatory cytokines in microglial cell lines. J Pineal Res (2010) 0.97
Neuronal cell survival: the role of interleukins. Ann N Y Acad Sci (2009) 0.96
Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus. PLoS One (2010) 0.96
Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: attenuation in CuZn-superoxide dismutase transgenic mice. Brain Res (1996) 0.95
Region-specific regulation of inflammation and pathogenesis in experimental autoimmune encephalomyelitis. J Neuroimmunol (2006) 0.94
Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem Res (2008) 0.94
Brain-region-specific astroglial responses in vitro after LPS exposure. J Mol Neurosci (2008) 0.93
Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res (1994) 0.92
Neuropsychiatric manifestations of depression in multiple sclerosis: neuroinflammatory, neuroendocrine, and neurotrophic mechanisms in the pathogenesis of immune-mediated depression. Dialogues Clin Neurosci (2007) 0.88
Silibinin attenuates cognitive deficits and decreases of dopamine and serotonin induced by repeated methamphetamine treatment. Behav Brain Res (2009) 0.88
Regional heterogeneity of dopaminergic deficits in vervet monkey striatum and substantia nigra after methamphetamine exposure. Exp Brain Res (2000) 0.86
Effects of methamphetamine on cortisone concentration, NK cell activity and mitogen response of T-lymphocytes in female cynomolgus monkeys. Exp Anim (2006) 0.85
First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain. J Pharmacol Exp Ther (2008) 0.84
A novel azaindolizinone derivative ZSET1446 (spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one) improves methamphetamine-induced impairment of recognition memory in mice by activating extracellular signal-regulated kinase 1/2. J Pharmacol Exp Ther (2006) 0.81
Amphetamine toxicity: behavioral and neuropathological indexes. Fed Proc (1975) 0.79
Differential effects of methamphetamine on Na(+)/Cl(-)-dependent transporters. Brain Res (2000) 0.79
Further confirmation of heterogeneity of the rat striatum: different mosaic patterns of dopamine fibers after administration of methamphetamine or reserpine. Brain Res (1986) 0.78
Cytokines and anxiety in systemic lupus erythematosus (SLE) patients not receiving antidepressant medication: a little-explored frontier and some of its brief history. Ann N Y Acad Sci (2009) 0.76
Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods (2005) 6.23
Lipid emulsion infusion rescues dogs from bupivacaine-induced cardiac toxicity. Reg Anesth Pain Med (2003) 3.87
The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend (2006) 3.38
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Lipid infusion accelerates removal of bupivacaine and recovery from bupivacaine toxicity in the isolated rat heart. Reg Anesth Pain Med (2006) 2.74
Use of a chitosan-based hemostatic dressing in dacryocystorhinostomy. Ophthal Plast Reconstr Surg (2009) 1.93
A comparison study of career satisfaction and emotional states between primary care and speciality residents. Med Educ (2006) 1.86
Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment. Drug Alcohol Depend (2008) 1.80
Measuring the influence of built neighborhood environments on walking in older adults. J Aging Phys Act (2006) 1.72
Cortical activation during delay discounting in abstinent methamphetamine dependent individuals. Psychopharmacology (Berl) (2008) 1.67
Gene expression profiling of whole blood: comparison of target preparation methods for accurate and reproducible microarray analysis. BMC Genomics (2009) 1.64
Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery. Crit Care Med (2004) 1.53
A novel approach to increase residents' involvement in reporting adverse events. Acad Med (2011) 1.47
Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med (2012) 1.44
Molecular architecture of the chick vestibular hair bundle. Nat Neurosci (2013) 1.43
High-throughput identification of proteins and unanticipated sequence modifications using a mass-based alignment algorithm for MS/MS de novo sequencing results. Anal Chem (2004) 1.42
The effect of bupivacaine on myocardial tissue hypoxia and acidosis during ventricular fibrillation. Anesth Analg (2004) 1.41
The OHRP and SUPPORT--another view. N Engl J Med (2013) 1.38
A role for Hox A5 in regulating angiogenesis and vascular patterning. Lymphat Res Biol (2005) 1.33
Unique gene expression profiles of donor-matched human retinal and choroidal vascular endothelial cells. Invest Ophthalmol Vis Sci (2007) 1.32
Antineutrophil cytoplasmic antibody-associated active scleritis. Arch Ophthalmol (2008) 1.28
Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest. Am J Ophthalmol (2008) 1.26
Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage (2010) 1.23
Hypothesis: sarcoidosis is a STAT1-mediated disease. Clin Immunol (2009) 1.10
Aortic valve replacement surgery: comparison of outcomes in matched sternotomy and PORT ACCESS groups. Ann Thorac Surg (2010) 1.07
Insights in to the pathogenesis of axial spondyloarthropathy based on gene expression profiles. Arthritis Res Ther (2009) 1.07
Distinct energy metabolism of auditory and vestibular sensory epithelia revealed by quantitative mass spectrometry using MS2 intensity. Proc Natl Acad Sci U S A (2012) 1.05
Causes of visual impairment and common eye problems in Northwest American Indians and Alaska Natives. Am J Public Health (2005) 1.03
Barriers to innovation in continuing medical education. J Contin Educ Health Prof (2008) 1.03
Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin. Mol Vis (2007) 1.02
The effects of electronic health record implementation on medical student educators. Teach Learn Med (2012) 1.01
Distinguishing tuberculosis from nontuberculous mycobacteria lung disease, Oregon, USA. Emerg Infect Dis (2011) 0.99
Reducing HIV-related risk behaviors among injection drug users in residential detoxification. AIDS Behav (2011) 0.99
Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res (2012) 0.99
Evaluation of electronic health record implementation in ophthalmology at an academic medical center (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc (2013) 0.97
Ocular disease in patients with ANCA-positive vasculitis. J Ocul Biol Dis Infor (2009) 0.95
Discounting of delayed rewards and executive dysfunction in individuals infected with hepatitis C. J Clin Exp Neuropsychol (2010) 0.93
A large GLC1C Greek family with a myocilin T377M mutation: inheritance and phenotypic variability. Invest Ophthalmol Vis Sci (2006) 0.93
Characterizing extravascular neutrophil migration in vivo in the iris. Inflammation (2008) 0.93
Extended medial gastrocnemius rotational flap for treatment of chronic knee extensor mechanism deficiency in patients with and without total knee arthroplasty. Clin Orthop Relat Res (2004) 0.92
Predictive value of frequency doubling technology perimetry for detecting glaucoma in a developing country. J Glaucoma (2005) 0.92
The impact of eyeglasses on vision-related quality of life in American Indian/Alaska Natives. Am J Ophthalmol (2010) 0.90
Predicting outpatient treatment entry following detoxification for injection drug use: the impact of patient and program factors. J Subst Abuse Treat (2010) 0.90
Digenic inheritance of deafness caused by 8J allele of myosin-VIIA and mutations in other Usher I genes. Hum Mol Genet (2012) 0.90
Plug the leak: align public spending with public need. J Grad Med Educ (2012) 0.89
Days to treatment and early retention among patients in treatment for alcohol and drug disorders. Addict Behav (2011) 0.88
Correlation of actin crosslinker and capper expression levels with stereocilia growth phases. Mol Cell Proteomics (2013) 0.87
Patient and provider comfort discussing substance use. Fam Med (2013) 0.86
Imaging Retinal Vascular Changes in the Mouse Model of Oxygen-Induced Retinopathy. Transl Vis Sci Technol (2012) 0.86
Frequency domain near-infrared spectroscopy technique in the assessment of brain oxygenation: a validation study in live subjects and cadavers. J Neurosci Methods (2006) 0.86
Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum (2011) 0.85
Clinical features associated with an Asp380His Myocilin mutation in a US family with primary open-angle glaucoma. Am J Ophthalmol (2007) 0.85
A mid year comparison study of career satisfaction and emotional states between residents and faculty at one academic medical center. BMC Med Educ (2006) 0.85
Personal time off and residents' career satisfaction, attitudes and emotions. Med Educ (2010) 0.84
Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord (2008) 0.84
Otitis media impacts hundreds of mouse middle and inner ear genes. PLoS One (2013) 0.84
Isoflurane is an effective alternative to ketamine/xylazine/acepromazine as an anesthetic agent for the mouse electroretinogram. Doc Ophthalmol (2007) 0.84
Association of interleukin 23 receptor gene with sarcoidosis. Dis Markers (2011) 0.84
T cell-antigen-presenting cell interactions visualized in vivo in a model of antigen-specific inflammation. Clin Immunol (2008) 0.84
"If you build it, they will come": attitudes of medical residents and fellows about seeking services in a resident wellness program. J Grad Med Educ (2013) 0.83
The influence of nurse home visits, including provision of 3 months of contraceptives and contraceptive counseling, on perceived barriers to contraceptive use and contraceptive use self-efficacy. Womens Health Issues (2008) 0.83
Cluster analysis of patients with ocular surface disease, blepharitis, and dry eye. Arch Ophthalmol (2004) 0.83
Agminated, eruptive pyogenic granuloma-like lesions developing over congenital vascular stains. Pediatr Dermatol (2011) 0.82
Five year outcomes study of dental rehabilitation conducted under general anesthesia for special needs patients. Anesth Prog (2007) 0.82
A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. Invest Ophthalmol Vis Sci (2005) 0.81
Adipocytokine signaling is altered in Flinders sensitive line rats, and adiponectin correlates in humans with some symptoms of depression. Pharmacol Biochem Behav (2012) 0.81
Awareness of and participation in maintenance of professional certification: a prospective study. J Contin Educ Health Prof (2007) 0.81
The effect of visual impairment on vision-related quality of life in American Indian/Alaska Natives. Ophthalmic Epidemiol (2009) 0.81
Promoting resident wellness: evaluation of a time-off policy to increase residents' utilization of health care services. Acad Med (2015) 0.80
Predicting permanent and transient protein-protein interfaces. Proteins (2013) 0.80
A survey of desired skills to acquire in ophthalmology training: a descriptive statistical analysis. Ophthalmic Surg Lasers Imaging (2007) 0.79
Characteristics and visual outcome of patients with retinal vasculitis. Arch Ophthalmol (2012) 0.79
Relationship of optic disk topography and visual function in patients with large cup-to-disk ratios. Am J Ophthalmol (2003) 0.78
Treatment length and outcomes among adolescents: a secondary data analysis. Subst Abuse Treat Prev Policy (2012) 0.78
A novel orally bioavailable inhibitor of kinase insert domain-containing receptor induces antiangiogenic effects and prevents tumor growth in vivo. Cancer Res (2004) 0.78
A comparison between physicians and demographically similar peers in accessing personal health care. Acad Med (2012) 0.78
Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration. Neuropharmacology (2011) 0.77
A patient-specific computer model to predict outcomes of the balloon occlusion test. J Neurosurg (2004) 0.77
Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol (2014) 0.77
Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis. J Ophthalmic Inflamm Infect (2012) 0.76
A feasibility study of methodology for recruitment and for comparative testing of ciliary function in Hawaiians and Caucasians. Hawaii Med J (2008) 0.76
Insights into uveitis in association with spondyloarthritis from a large patient survey. J Clin Rheumatol (2014) 0.75
Possible association between scleritis and lymphoma. Br J Ophthalmol (2007) 0.75
Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina (2009) 0.75
Effect of age on brain oxygenation regulation during changes in position. J Neurosci Methods (2007) 0.75
Corrigendum: Stereocilia-staircase spacing is influenced by myosin III motors and their cargos espin-1 and espin-like. Nat Commun (2017) 0.75
Comparison of digital fundus photographic and echographic measurements for maximal linear dimension from eyes with choroidal melanoma. Retina (2009) 0.75
[ Factors influence the spatial and geographic distribution of hypertension in Jiangsu Province]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 0.75
Education to return nonpracticing physicians to clinical activity: a case study in physician reentry. J Contin Educ Health Prof (2010) 0.75
Medical fitness evaluation for respirator users: results of a national survey of private sector employers. J Occup Environ Med (2007) 0.75
Erratum: Prediction of cis-regulatory elements controlling genes differentially expressed by retinal and choroidal vascular endothelial cells. J Ocul Biol Dis Infor (2008) 0.75
Determinants of Patient Satisfaction in an Academic Rheumatology Practice. J Clin Rheumatol (2015) 0.75
A functional clotting assay to monitor the hirudin dosage. Blood Coagul Fibrinolysis (2007) 0.75